Nick Haft
Fondatore presso Delix Therapeutics, Inc.
Profilo
Nick is a Managing Director with OMX Ventures.
Prior to OMX, Nick was the sole managing partner at Arcos Ventures, where he deployed over $80M of capital into 20+ bio-related companies.
Some of Nick’s prior investments include Finch Therapeutics, Pendulum Therapeutics, Ginkgo Bioworks, 10X Genomics, Imagen, Compass Pathways and many others.
Nick also co-founded Delix Therapeutics, a startup focused on developing breakthrough therapies for psychiatric and neurological disorders.
Education: Bachelor of Science in Economics, Wharton School, University of Pennsylvania
Posizioni attive di Nick Haft
| Società | Posizione | Inizio |
|---|---|---|
Omx Ventures LLC
 Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | Investitore di Private Equity | 01/03/2020 |
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Fondatore | 01/07/2019 |
Precedenti posizioni note di Nick Haft
| Società | Posizione | Fine |
|---|---|---|
| Arcos Ventures SPV LLC | Investitore di Private Equity | 01/02/2020 |
Formazione di Nick Haft
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | Finance |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | Health Technology |
| Arcos Ventures SPV LLC |
- Borsa valori
- Insiders
- Nick Haft
